MedTrace Logo

Outcomes of Critically Ill Patients With Hematologic Malignancies

NCT06410066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2024-05-10

No results posted yet for this study

Summary

The investigators sought to report the outcomes of patients with haematological malignancies admitted to the intensive care units and to define pre-intensive care units prognostic factors for in-hospital all-cause mortality.

In this retrospective, single-center study, all patients with haematologic malignancies admitted to intensive care units between 2009 and 2019 were included. The primary outcome was in-hospital mortality.

Conditions

  • Hematologic Malignancy

Interventions

OTHER

no intervention

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2019-12-31
Completion
2022-01-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06410066 on ClinicalTrials.gov